Cisbio Cisbio is a company that develops and markets products and technologies used for in vitro diagnostics and drug discovery. | ![]() DiaSorin DiaSorin is a company that develops, produces, and commercializes reagent kits and instruments for diagnosis and research. | ![]() Source Bioscience Source BioScience is an international genetic analysis and diagnostics company serving the healthcare and life science research markets. | Stemina Biomarker Discovery Stemina Biomarker Discovery is a metabolomics company focused on the discovery, development, and commercialization of molecular biomarkers. | |
Founding Date | Founding Date 1985 | Founding Date 1968 | Founding Date N/A | Founding Date 2006 |
Type | Type Subsidiary | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Codolet, FR HQ | Locations Saluggia, IT HQ Macquarie Park, AU Wien, AT Anderlecht, BE San Paolo, BR Mississauga, CA Shanghai, CN see more | Locations Nottingham, GB HQ Dublin 9, IE Tramore, IE Cambridge, GB Kingsway Business Park, GB San Diego, US | Locations HQ |
Employees | Employees 1111% decrease | Employees 3,249 | Employees 2043% increase | Employees 11 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €1.2b (FY, 2025) | Revenue (est.) £13.6m (FY, 2017) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods €293.3m (FY, 2025) | Cost of goods £8.2m (FY, 2017) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €901.7m (FY, 2025) | Gross profit £5.4m (FY, 2017) | Gross profit N/A |
Net income | Net income N/A | Net income €150m (FY, 2025) | Net income (£5.3m) (FY, 2017) | Net income N/A |

DiaSorin is a company that develops, produces, and commercializes reagent kits and instruments for diagnosis and research.
View company
Source BioScience is an international genetic analysis and diagnostics company serving the healthcare and life science research markets.
View companyStemina Biomarker Discovery is a metabolomics company focused on the discovery, development, and commercialization of molecular biomarkers.
View company